> Skip repeated content
photo of Lindsay S. Lally, MD

Lindsay S. Lally, MD

phone icon

About Dr. Lally


Dr. Lally specializes in the care of patients with various rheumatic conditions including vasculitis, systemic lupus erythematosus, scleroderma and rheumatoid arthritis and has a particular interest in the systemic vasculitides. Dr. Lally is actively involved as an investigator in numerous clinical and translational studies focusing on vasculitis and has been the recipient of several awards including a Vasculitis Foundation Research Grant and the American College of Rheumatology Distinguished Fellow Award.

Dr. Lally received her Bachelor of Arts from Princeton University and her medical degree from Weill Cornell Medical College. She completed her residency in Internal Medicine at NewYork-Presbyterian Hospital - Weill Cornell Medical Center followed by her Rheumatology Fellowship at Hospital for Special Surgery.

Profile Video


Specialized Centers

Scleroderma, Vasculitis & Myositis Center of Excellence

Special Expertise

Sjogren’s Syndrome
Systemic Lupus Erythematosus/Antiphospholipid Antibody Syndrome
Inflammatory Arthritis


Intra-articular and intra-bursal aspirations and injections

Patient Stories


Patient ratings for Dr. Lally


Learn more about our patient ratings.


If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.



Assistant Attending Rheumatologist, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College


American College of Rheumatology


Internal Medicine


Vasculitis Foundation Research Grant, 2013
American College of Rheumatology Distinguished Fellow Award, 2013
Weill Cornell Alumni Organization Distinguished Housestaff Award, 2010
William C. Thro Memorial Prize for pathophysiology, 2008
Alpha Omega Alpha Honor Society, 2007


MD, Weill Cornell Medical College, New York, 2008


Internal Medicine, NewYork-Presbyterian Hospital-Cornell


Internal Medicine, NewYork-Presbyterian Hospital-Cornell


Hospital for Special Surgery, NY

State Licensure



Publications by Dr. Lally

Selected Journal Articles

Lally L, Spiera RF.  Current Landscape of ANCA-Associated Vasculitis: Classification, Diagnosis and Treatment. Rheum Dis Clin North Am. 2015;41(1):1-19. 

Lally L, Sammaritano LR. Vasculitis in Antiphospholipid syndrome. Rheum Dis Clin North Am. 2015;41(1):109-23.

Lally L, Spiera RF.  Current therapies for ANCA-associated vasculitis.  Annual Review of Medicine 2014, volume 66 in press 

Lally L, Pernis A, Narula N, Huang WT and Spiera RF. Increased Rho Kinase Activity in Temporal Artery Biopsies from Patients with Giant Cell Arteritis. Rheumatology (Oxford)  2014.

Lally L, Lebovics RS, Huang-WT, Spiera RF.  Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangitiitis.  Arthritis Care Res 2014;66(9)1403-9.

Lally L, Spiera RF.  Biomarkers in ANCA-Associated Vasculitis.  Curr Rheumatol Rep.  2013;15:363

Selected Books/Chapters

Lally L, Paget S. Clinical Approach to Patients with Vasculitis. In: The Vasculitidies: General Considerations and Systemic Vasculitis. (Ed Younger D) Nova Scientific, 2014.

Lally L, Spiera RF.  Vasculitis in Pregnancy. In: Contraception and Pregnancy in Patients with Rheumatic Disease.  (Ed Sammaritano LR and Bermas BL) Springer, 2014. 

Erkan D, Lally L, and Lockshin M.  What Should Patients Know about Antiphospholipid Antibodies and Antiphospholipid Syndrome? In: Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies. (Eds Erkan D and Pierangeli S) Springer, 2012.

Selected Presentations

Increased Rho Kinase (ROCK) Activity in Temporal Arterial Biopsies from Patients with Giant Cell Arteritis (GCA), American College of Rheumatology Annual Scientific Meeting, San Diego, CA, Oct 25-30, 2013.   oral presentation

Efficacy of Rituximab for Otolaryngologic (ENT) Manifestations of Granulomatosis with Polyangiitis (GPA, Wegener’s granulomatosis), American College of Rheumatology Annual Scientific Meeting, San Diego, CA, Oct 25-30, 2013.    poster presentation

Increased Rho Kinase (ROCK) Activity in Temporal Arterial Biopsies from Patients with Giant Cell Arteritis (GCA). International Giant Cell Arteritis, Polymyalgia Rheumatica and Large Vessel Vasculitis Symposium, Southend, UK November 2013 oral presentation

Rho Kinase (ROCK) Activity in Aortitis: Comparison of Giant Cell Arteritis, Takayasu Arteritis, and Isolated Aortitis. American College of Rheumatology Annual Scientific Meeting, Boston, MA, Nov 16-19, 2014. poster presentation


Research Interests

Polymyalgia Rheumatica

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

Below are the healthcare industry relationships reported by Dr. Lally as of March 23, 2023.

Amgen, Inc. - Consultant

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.

Patients should feel free to ask their HSS physicians questions about these relationships.

Dr. Lally in the News